Results 21 to 30 of about 1,382,625 (239)
Adoptive Immunotherapy and High-Risk Myeloma
, 2023 Despite significant improvements in the treatment of multiple myeloma (MM), it remains mostly incurable, highlighting a need for new therapeutic approaches.
Michael O’Dwyer +2 more
core +1 more source
Transgenic T-cell receptor immunotherapy for cancer: building on clinical success
Therapeutic Advances in Vaccines and Immunotherapy, 2020 With the advent of immunotherapy as a realistic and promising option for cancer treatment, adoptive cellular therapies are gaining significant interest in the clinic.
Natasha Oppermans +3 more
doaj +1 more source
Light-responsive nanomedicine for cancer immunotherapy
Acta Pharmaceutica Sinica B, 2023 Immunotherapy emerged as a paradigm shift in cancer treatments, which can effectively inhibit cancer progression by activating the immune system. Remarkable clinical outcomes have been achieved through recent advances in cancer immunotherapy, including ...
Weirong Kang, Yuwei Liu, Weiping Wang
doaj +1 more source
Chimeric Antigen Receptor T Cell Therapy in Hematology
Turkish Journal of Hematology, 2015 It is well demonstrated that the immune system can control and eliminate cancer cells. Immune-mediated elimination of tumor cells has been discovered and is the basis of both cancer vaccines and cellular therapies including hematopoietic stem cell ...
Pınar Ataca, Önder Arslan
doaj +1 more source
Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective
Cells, 2021 The term “cancer stem cells” (CSCs) commonly refers to a subset of tumor cells endowed with stemness features, potentially involved in chemo-resistance and disease relapses.
Chiara Donini +5 more
doaj +1 more source
Targeting macrophages in cancer immunotherapy
Signal Transduction and Targeted Therapy, 2021 Immunotherapy is regarded as the most promising treatment for cancers. Various cancer immunotherapies, including adoptive cellular immunotherapy, tumor vaccines, antibodies, immune checkpoint inhibitors, and small-molecule inhibitors, have achieved ...
Zhaojun Duan, Yunping Luo
doaj +1 more source
Prospects of Immunotherapy for Triple-Negative Breast Cancer
Frontiers in Oncology, 2022 In the classification and typing of breast cancer, triple-negative breast cancer (TNBC) is one type of refractory breast cancer, while chemotherapy stays in the traditional treatment methods.
Dan Qiu +12 more
doaj +1 more source
Cellular immunotherapies for cancer
OncoImmunology, 2017 Lessons learned over decades on the use of gene and cell therapies have found clinical applicability in the field of cancer immunotherapy. On December 16th, 2016 a symposium was held in Pamplona (Spain) to analyze and discuss the critical points for the ...
Pedro Berraondo +7 more
doaj +1 more source
Role of Immune Cells and Receptors in Cancer Treatment: An Immunotherapeutic Approach
Vaccines, 2022 Cancer immunotherapy moderates the immune system’s ability to fight cancer. Due to its extreme complexity, scientists are working to put together all the puzzle pieces to get a clearer picture of the immune system.
Anirban Goutam Mukherjee +11 more
doaj +1 more source
Genetic modification and effector functions of natural killer cells in acute myeloid leukemia [PDF]
, 2006 Acute myeloid leukemia (AML) is characterized by a poor long-term outcome in the majority of patients following conventional treatment with chemotherapy.
Siegler, Uwe
core +1 more source